Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Sell
14,900
-300
-2% -$7.07K 0.01% 876
2026
Q1
$346K Buy
+15,200
New +$359K 0.01% 821
2019
Q4
Sell
-26,740
Closed -$1.34M 1599
2019
Q3
$1.34M Buy
+26,740
New +$1.26M 0.02% 716

Other funds holding ENOV

Winton Group's ENOV Position: Q2 2026 in Review

Winton Group reduced its Enovis (ENOV) stake by 2% in Q2 2026, selling an estimated $7.07K and leaving 14,900 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #876.

Winton Group first reported a position in ENOV in Q3 2019 and has held it in 3 quarters since. The position peaked at $1.34M in Q3 2019. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Winton Group held 14,900 shares of Enovis worth $308K as of Q2 2026.
  • Winton Group sold 300 Enovis shares in Q2 2026, an estimated $7.07K.
  • Enovis made up 0.01% of Winton Group's portfolio in Q2 2026, its #876 holding.
  • Winton Group first reported a position in Enovis in Q3 2019 and has held it in 3 quarters since.
  • Winton Group's Enovis position peaked at $1.34M in Q3 2019.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.